Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143791-43-9

Post Buying Request

143791-43-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143791-43-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 143791-43-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,7,9 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 143791-43:
(8*1)+(7*4)+(6*3)+(5*7)+(4*9)+(3*1)+(2*4)+(1*3)=139
139 % 10 = 9
So 143791-43-9 is a valid CAS Registry Number.
InChI:InChI=1/C26H32N6O6S/c1-14(21(28)33)29-24(36)20(13-16-6-4-3-5-7-16)31-25(37)26(38)32-22(34)15(2)30-23(35)19(27)12-17-8-10-18(39)11-9-17/h3-11,14-15,19-20,39H,12-13,27H2,1-2H3,(H2,28,33)(H,29,36)(H,30,35)(H,31,37)(H,32,34,38)/t14-,15+,19-,20-/m0/s1

143791-43-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[(2S)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-N'-[(2R)-2-[[(2S)-2-amino-3-(4-sulfanylphenyl)propanoyl]amino]propanoyl]oxamide

1.2 Other means of identification

Product number -
Other names 2,5-Ala-enkephalinamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143791-43-9 SDS

143791-43-9Downstream Products

143791-43-9Relevant articles and documents

Synthesis and conformational properties of the lanthionine-bridged opioid peptide [D-Ala(L)2,Ala(L)5]enkephalin as determined by NMR and computer simulations

Polinsky,Cooney,Toy-Palmer,Osapay,Goodman

, p. 4185 - 4194 (2007/10/02)

We report the synthesis and conformational analysis by means of NMR and computer simulations of a novel opioid peptide with the sequence [D-Ala(L)2, L-Ala(L)5]EA, where Ala(L) denotes each of the lanthionine amino acid ends linked by a monosulfide bridge and EA indicates enkephalinamide. Data from 2D NMR (HOHAHA and ROESY) provide short-range NOEs that are used as constraints in molecular modeling; measurement of coupling constants shows that χ1 (D- Ala(L)2) is predominantly in either the t or g- conformation, and temperature coefficient data suggest the participation of the Ala(L)5 amide proton in an intramolecular hydrogen bond. The use of NOE and hydrogen-bond constraints in a distance-geometry program yields a large number of initial conformations compatible with the data. Energy minimization of these structures using CHARMM results in three families of backbone ring conformations, labeled A1, A2, and B. The torsion χ1 in D-Ala(L)2 remains close to trans for all three conformations. Molecular dynamics in vacuo at 300 K show that these three families of conformers interconvert, with concerted shifts in two of the three torsions ψ(Phe), φ(Ala(L)5), and χ(Ala(L)5). The [D-Ala(L)2,L-Ala(L)5]EA is superactive in the guinea pig ileum (GPI) and mouse vas deferens (MVD) in vitro tests and also in the rat hot plate test in vivo. At the same time, this analog with a constrained 13- membered ring shows virtually no selectivity with a ratio IC50 (MVD)/IC50 (GPI) of 0.882.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143791-43-9